13F Filings History of Rodgers Brothers Inc.

Latest 13F report
Q4 2025 - 13 Feb 2026
Value $
$835,392,334
Signature - Title
Mark Rodgers - President
Location
Harmony, PA
Summary
This page shows a list of all the recent 13F filings made by Rodgers Brothers Inc.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Rodgers Brothers Inc. reported 238 stock holdings with total value $835,392,334 as of Q4 2025. Top holdings included COHR, LLY, ABBV, WSM, and MSFT.

Notify me when Rodgers Brothers Inc. files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 238 $835,392,334 +$23,158,544 -$52,617,705 -$29,459,161 COHR, LLY, ABBV, WSM, MSFT 13F-HR 13 Feb 2026, 13:14
Q3 2025 235 $811,727,782 +$33,924,669 -$47,592,916 -$13,668,247 COHR, LLY, ABBV, WSM, MSFT 13F-HR 12 Nov 2025, 09:01
Q2 2025 237 $792,458,768 +$52,756,302 -$38,825,223 +$13,931,079 LLY, COHR, ABBV, WSM, BMI 13F-HR 14 Aug 2025, 10:54
Q1 2025 234 $751,097,191 +$48,767,104 -$46,030,812 +$2,736,292 LLY, COHR, ABBV, WSM, PG 13F-HR 14 May 2025, 13:18
Q4 2024 230 $766,702,444 +$45,157,990 -$42,178,122 +$2,979,868 LLY, COHR, WSM, ABBV, PG 13F-HR 12 Feb 2025, 13:01
Q3 2024 235 $787,456,476 +$48,711,254 -$42,514,475 +$6,196,779 LLY, COHR, ABBV, WSM, PG 13F-HR 14 Nov 2024, 15:06
Q2 2024 239 $738,463,652 +$52,371,283 -$41,440,437 +$10,930,846 LLY, COHR, ABBV, WSM, PG 13F-HR 14 Aug 2024, 15:35
Q1 2024 239 $732,583,692 +$59,310,858 -$35,139,417 +$24,171,441 LLY, ABBV, COHR, WSM, PG 13F-HR 14 May 2024, 16:13
Q4 2023 227 $633,617,138 +$26,795,504 -$32,624,007 -$5,828,503 LLY, WSM, ABBV, COHR, PG 13F-HR 13 Feb 2024, 14:38
Q3 2023 219 $585,863,410 +$54,710,172 -$14,303,261 +$40,406,911 LLY, ABBV, PG, WSM, EMR 13F-HR 13 Nov 2023, 16:18
Q2 2023 206 $567,982,103 +$49,296,036 -$25,645,415 +$23,650,621 LLY, COHR, PG, ABBV, ABT 13F-HR 14 Aug 2023, 16:25
Q1 2023 207 $520,797,430 +$40,959,729 -$22,342,481 +$18,617,248 LLY, ABBV, PG, ABT, COHR 13F-HR 15 May 2023, 14:02
Q4 2022 197 $497,553,069 +$15,361,900 -$42,139,799 -$26,777,899 LLY, ABBV, PG, ABT, COHR 13F-HR 14 Feb 2023, 16:55
Q3 2022 194 $469,341,000 +$40,929,030 -$40,649,410 +$279,620 LLY, ABBV, PG, ABT, COHR 13F-HR 14 Nov 2022, 15:37
Q2 2022 192 $506,012,000 +$23,489,460 -$20,376,039 +$3,113,421 LLY, ABBV, IIVI, PG, ABT 13F-HR 15 Aug 2022, 16:21
Q1 2022 197 $556,964,000 +$40,251,512 -$33,405,210 +$6,846,302 LLY, IIVI, ABBV, PG, ABT 13F-HR 16 May 2022, 10:34
Q4 2021 207 $561,811,000 +$27,622,785 -$16,278,359 +$11,344,426 LLY, IIVI, PG, STX, ABBV 13F-HR 14 Feb 2022, 11:10
Q3 2021 191 $501,535,000 +$19,340,902 -$23,545,242 -$4,204,340 IIVI, LLY, PG, ABT, ABBV 13F-HR 15 Nov 2021, 13:21
Q2 2021 197 $522,407,000 +$47,398,204 -$29,397,594 +$18,000,610 IIVI, LLY, ABBV, PG, ABT 13F-HR 16 Aug 2021, 11:46
Q1 2021 193 $483,606,000 +$38,122,382 -$24,290,211 +$13,832,171 IIVI, LLY, PG, ABBV, ABT 13F-HR 17 May 2021, 16:24
Q4 2020 180 $436,798,000 +$19,837,430 -$18,670,661 +$1,166,769 IIVI, ABBV, PG, LLY, ABT 13F-HR 16 Feb 2021, 15:21
Q3 2020 183 $386,677,000 +$19,748,650 -$19,301,707 +$446,943 PG, ABT, LLY, IIVI, ABBV 13F-HR 13 Nov 2020, 16:27
Q2 2020 187 $368,939,000 +$22,755,622 -$21,201,610 +$1,554,012 IIVI, LLY, ABBV, PG, ABT 13F-HR 13 Aug 2020, 17:26
Q1 2020 185 $315,174,000 +$27,698,198 -$17,711,847 +$9,986,351 LLY, PG, IIVI, ABBV, ABT 13F-HR 14 May 2020, 12:08
Q4 2019 190 $384,481,000 +$16,520,303 -$15,249,285 +$1,271,018 IIVI, PG, LLY, ABBV, ABT 13F-HR 13 Feb 2020, 10:50
Q3 2019 186 $361,120,000 +$18,941,520 -$21,624,083 -$2,682,563 IIVI, PG, LLY, ABT, ABBV 13F-HR 14 Nov 2019, 14:37
Q2 2019 193 $359,675,000 +$27,428,961 -$22,681,298 +$4,747,663 IIVI, PG, ABT, LLY, ABBV 13F-HR 14 Aug 2019, 12:24
Q1 2019 190 $351,157,000 +$17,303,478 -$11,622,955 +$5,680,523 IIVI, PG, LLY, ABT, ABBV 13F-HR 15 May 2019, 14:25
Q4 2018 186 $310,893,001 +$15,484,228 -$13,895,669 +$1,588,559 IIVI, PG, LLY, ABBV, ABT 13F-HR 14 Feb 2019, 16:06
Q3 2018 193 $348,041,000 +$13,470,004 -$17,946,776 -$4,476,772 IIVI, ABBV, JNJ, LLY, PG 13F-HR 14 Nov 2018, 16:11
Q2 2018 195 $327,789,000 +$22,422,798 -$6,693,461 +$15,729,337 IIVI, ABBV, JNJ, PG, LLY 13F-HR 14 Aug 2018, 09:12
Q1 2018 183 $306,219,000 +$22,283,773 -$9,070,226 +$13,213,547 IIVI, ABBV, JNJ, PG, LLY 13F-HR 15 May 2018, 15:05
Q4 2017 175 $306,623,000 +$18,506,165 -$12,719,060 +$5,787,105 IIVI, ABBV, JNJ, PG, LLY 13F-HR 14 Feb 2018, 18:06
Q3 2017 165 $284,217,000 +$17,800,104 -$16,874,632 +$925,472 IIVI, ABBV, PG, JNJ, LLY 13F-HR 08 Nov 2017, 17:00
Q2 2017 171 $271,055,000 +$10,276,325 -$5,783,673 +$4,492,652 IIVI, JNJ, PG, ABBV, LLY 13F-HR 14 Aug 2017, 13:27
Q1 2017 169 $264,891,000 +$9,980,878 -$13,306,375 -$3,325,497 IIVI, PG, JNJ, LLY, ABBV 13F-HR 15 May 2017, 13:18
Q4 2016 168 $255,041,000 +$8,334,987 -$9,706,185 -$1,371,198 IIVI, PG, JNJ, XOM, ABBV 13F-HR 14 Feb 2017, 16:16
Q3 2016 172 $248,842,000 +$8,256,265 -$7,906,150 +$350,115 IIVI, PG, JNJ, ABBV, LLY 13F-HR 14 Nov 2016, 16:09
Q2 2016 173 $242,854,000 +$12,787,810 -$7,475,391 +$5,312,419 IIVI, PG, JNJ, VZ, XOM 13F-HR 15 Aug 2016, 15:20
Q1 2016 172 $229,762,000 +$11,528,968 -$6,010,909 +$5,518,059 IIVI, PG, JNJ, VZ, XOM 13F-HR 16 May 2016, 15:02
Q4 2015 166 $214,022,000 +$12,774,409 -$8,946,173 +$3,828,236 IIVI, PG, JNJ, LLY, ABBV 13F-HR 16 Feb 2016, 15:07
Q3 2015 157 $199,037,000 +$12,041,257 -$4,203,936 +$7,837,321 IIVI, LLY, PG, JNJ, ABBV 13F-HR 16 Nov 2015, 10:24
Q2 2015 158 $211,418,000 +$14,363,099 -$4,720,903 +$9,642,196 IIVI, LLY, ABBV, PG, VZ 13F-HR 14 Aug 2015, 14:10
Q1 2015 155 $204,678,000 +$8,034,415 -$4,792,659 +$3,241,756 IIVI, VZ, XOM, LLY, JNJ 13F-HR 15 May 2015, 11:57
Q4 2014 150 $200,391,000 +$12,801,054 -$10,047,811 +$2,753,243 IIVI, XOM, ABBV, JNJ, VZ 13F-HR 17 Feb 2015, 16:28
Q3 2014 146 $191,558,000 +$2,883,189 -$5,787,603 -$2,904,414 IIVI, XOM, VZ, JNJ, ABBV 13F-HR 14 Nov 2014, 14:53
Q2 2014 147 $202,075,000 +$6,047,375 -$16,118,183 -$10,070,808 IIVI, XOM, VZ, JNJ, ABBV 13F-HR 14 Aug 2014, 17:52
Q1 2014 168 $205,127,000 +$8,411,955 -$2,907,634 +$5,504,321 IIVI, XOM, VZ, JNJ, ABBV 13F-HR 15 May 2014, 14:26
Q4 2013 162 $201,774,000 $0 $0 $0 IIVI, XOM, VZ, JNJ, ABBV 13F-HR 13 Feb 2014, 17:26